Ledger.Open graph →
SEC Form D · filed August 6, 2021

Biothea Pharma, Inc

Offering
$22.0M
Sold
$22.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Boston, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Marina S. Bozilenko · Boston, MAExec · DirectorAnthony J. Aiudi · Boston, MADirectorJean-Pierre J. Sommadossi, Ph.D · Boston, MADirectorRohit J. Mehta · Boston, MAExecVanessa Otero · Westminster, CODirectorTorbjorn J. Bjerke · Boston, MADirectorAndrea J. Corcoran · Boston, MAExecMadhavi N. Jain · Austin, TXDirectorTorbjorn J. Bjerke · Boston, MADirectorMarina S. Bozilenko · Boston, MAExec · DirectorAnthony J. Aiudi · Boston, MADirectorAndrea J. Corcoran · Boston, MAExecRohit J. Mehta · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗